Free Trial

Zacks Research Has Pessimistic Opinion of CVSA Q2 Earnings

Key Points

  • Zacks cut its Q2 2027 EPS forecast for Adtalem Global Education to $2.11 from $2.38.
  • Adtalem reported quarterly EPS of $2.19, beating the $1.90 consensus estimate, with revenue of $511.53 million.
  • Analysts have a consensus Hold rating and an average price target of $151.67.
  • Five stocks we like better than Adtalem Global Education.

Adtalem Global Education Inc. (NYSE:CVSA - Free Report) - Zacks Research lowered their Q2 2027 earnings per share estimates for shares of Adtalem Global Education in a research report issued on Friday, November 13th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $2.11 for the quarter, down from their previous estimate of $2.38. The consensus estimate for Adtalem Global Education's current full-year earnings is $9.08 per share. Zacks Research also issued estimates for Adtalem Global Education's Q4 2027 earnings at $2.38 EPS, FY2027 earnings at $9.04 EPS, Q1 2028 earnings at $2.35 EPS, Q2 2028 earnings at $2.42 EPS, Q3 2028 earnings at $2.57 EPS, Q4 2028 earnings at $2.68 EPS, FY2028 earnings at $10.01 EPS, Q1 2029 earnings at $2.66 EPS and FY2029 earnings at $11.61 EPS.

Adtalem Global Education (NYSE:CVSA - Get Free Report) last announced its earnings results on Thursday, October 29th. The company reported $2.19 EPS for the quarter, beating the consensus estimate of $1.90 by $0.29. Adtalem Global Education had a return on equity of 21.79% and a net margin of 12.84%. The company had revenue of $511.53 million for the quarter.

Several other equities analysts have also issued reports on the company. Weiss Ratings raised Adtalem Global Education from a "hold (c)" rating to a "hold (c+)" rating in a research note on Wednesday, October 21st. Wall Street Zen raised shares of Adtalem Global Education from a "hold" rating to a "buy" rating in a research report on Sunday, September 27th. BMO Capital Markets reduced their price objective on shares of Adtalem Global Education from $148.00 to $145.00 and set an "outperform" rating for the company in a research report on Monday, October 5th. Finally, Truist Financial lowered shares of Adtalem Global Education from a "buy" rating to a "hold" rating and set a $140.00 price objective for the company. in a research note on Thursday, September 3rd. Two investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Adtalem Global Education currently has an average rating of "Hold" and a consensus price target of $151.67.

Check Out Our Latest Report on CVSA

Adtalem Global Education Trading Up 0.2%

Shares of CVSA stock opened at $118.35 on Monday. The company has a market cap of $3.94 billion, a P/E ratio of 16.17, a PEG ratio of 0.87 and a beta of 0.70. The stock has a 50 day simple moving average of $124.74 and a two-hundred day simple moving average of $121.85. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.81 and a current ratio of 0.81. Adtalem Global Education has a fifty-two week low of $86.97 and a fifty-two week high of $142.13.

Institutional Investors Weigh In On Adtalem Global Education

A hedge fund recently raised its position in Adtalem Global Education stock. Kendall Capital Management lifted its position in shares of Adtalem Global Education Inc. (NYSE:CVSA - Free Report) by 23.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,375 shares of the company's stock after purchasing an additional 2,753 shares during the quarter. Kendall Capital Management's holdings in Adtalem Global Education were worth $1,757,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 98.84% of the company's stock.

Insider Transactions at Adtalem Global Education

In related news, CEO Stephen W. Beard sold 4,667 shares of the business's stock in a transaction dated Friday, October 9th. The stock was sold at an average price of $130.77, for a total value of $610,303.59. Following the completion of the sale, the chief executive officer directly owned 469,158 shares of the company's stock, valued at $61,351,791.66. The trade was a 0.98% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Manjunath Gangadharan sold 1,802 shares of the company's stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $137.18, for a total value of $247,198.36. Following the transaction, the chief accounting officer directly owned 5,083 shares in the company, valued at approximately $697,285.94. This trade represents a 26.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 10,108 shares of company stock worth $1,331,918 in the last three months. Insiders own 2.70% of the company's stock.

Top Adtalem Global Education Stories

Investors following CVSA have been watching these stories:

  • Positive Sentiment: Zacks raised its full-year EPS estimates to $9.04 for FY2027, $10.01 for FY2028 and $11.61 for FY2029. It also increased several quarterly forecasts, including Q4 2028 to $2.68 from $2.59. Higher projections point to improving expected earnings over time. MarketBeat report
  • Negative Sentiment: Zacks lowered its Q2 2027 EPS estimate to $2.11 from $2.38 and its Q2 2028 estimate to $2.42 from $2.56, indicating weaker expectations for those periods. MarketBeat report

About Adtalem Global Education

(Get Free Report)

Adtalem Global Education is a U.S.-based education company focused primarily on healthcare and professional education. Its institutions offer undergraduate and graduate degree programs, professional training, and online learning for students preparing for careers in fields such as nursing, medicine, veterinary medicine, and business. Its institutions include Chamberlain University, Walden University, the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.

Read More

Earnings History and Estimates for Adtalem Global Education (NYSE:CVSA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Adtalem Global Education Right Now?

Before you consider Adtalem Global Education, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adtalem Global Education wasn't on the list.

While Adtalem Global Education currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines